• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Repatha samples & Mike Tuller

Every know-nothing in Thousand Oaks who was last in sales 20 years ago targets samples. Supported by the legions of ZS dorks who can't think outside their silo. Samples are an easy target. Cuts cost for the current quarter and gets a promotion before the inevitable destruction of future sales.
 




Every know-nothing in Thousand Oaks who was last in sales 20 years ago targets samples. Supported by the legions of ZS dorks who can't think outside their silo. Samples are an easy target. Cuts cost for the current quarter and gets a promotion before the inevitable destruction of future sales.
Every MBA candidate targets samples for cost saving and they get floated up to the ED who are already under tremendous pressure from all the ZS infiltrators who are now Amgen Sr. Directors so the pressure gets immense. In total, these clowns have spent zero days in front of customers and couldn't sell aspirin in a headache ward.
 




Every MBA candidate targets samples for cost saving and they get floated up to the ED who are already under tremendous pressure from all the ZS infiltrators who are now Amgen Sr. Directors so the pressure gets immense. In total, these clowns have spent zero days in front of customers and couldn't sell aspirin in a headache ward.
a lot of public school on display
 
























Samples sell. Period.

The simpletons only see the sample cost and think, golly we could save a lot by cutting samples.

Answer this, how often does someone start Repatha without a sample?

TO always gonna do what TO does which is look around for something to measure and then focus on it for a while to convince Lucky Charms, Biker Boy and Big Bobby that they are on their game.

It will pass.

It will be something else next, but it will pass.
 








Samples sell. Period.

The simpletons only see the sample cost and think, golly we could save a lot by cutting samples.

Answer this, how often does someone start Repatha without a sample?

TO always gonna do what TO does which is look around for something to measure and then focus on it for a while to convince Lucky Charms, Biker Boy and Big Bobby that they are on their game.

It will pass.

It will be something else next, but it will pass.

We have gone from quantification to sample reduction, now let’s move on to the most stupid thing of all …. Telling the Dr “what if a heart attack victims wife was in a patient room mad at him”